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Carbon Disulfide
The September 1998 issue of EHP con-
tained two articles about the neurotoxicity
of carbon disulfide. The "NIEHS News"
article (1) reported on a collaborative study
that involved scientists from the NIEHS
(Research Triangle Park, NC), the U.S.
Environmental Protection Agency
(Research Triangle Park, NC), the
University ofNorth Carolina (Chapel Hill,
NC), Duke University (Durham, NC), and
Vanderbilt University (Nashville, TN). In
this study, the neurotoxicity of carbon
disulfide was detailed from the earliest mol-
ecular alterations to neurobehavioral find-
ings to electrophysiologic and morphologic
changes, and the utility of intramolecular
cross-linking in hemoglobin as a biomarker
was defined. I was pleased to read this
report, and even more pleased to have par-
ticipated in this study, but I was distressed
to see the cover story in the same issue.
"Multiple System Atrophy Following
Chronic Carbon Disulfide Exposure" (2),
in the "Grand Rounds in Environmental
Medicine," is a case report ofan individual
who developed a degenerative nervous sys-
tem disease, olivopontocerebellar atrophy,
and who had been chronically exposed to
carbon disulfide while working for 34 years
in a viscose rayon plant in the United
States. Frumkin (2) concluded, "While this
association has not previously been report-
ed, it is clinically and pathologically consis-
tent with a range of movement disorders
seen in the setting of occupational carbon
disulfide exposure."
Frumkin never saw this patient, nor
was he consulted by the patient's physi-
cians during the course of this disease; he
only reviewed the medical records and
diagnostic studies as an expert witness for
the plaintiff in a case that failed to con-
vince a Texas jury that a cause-and-effect
relationship existed between carbon disul-
fide exposure and this man's disease (3). I
also reviewed this material and concluded
that such a relationship was not even
remotely plausible; indeed, I thought that
there were excellent reasons to conclude
that his disease bore no relationship to the
exposure. Thus, the publication of this
paper raises several concerns: Why did
Frumkin feel authorized to publish this
report, and were the editors informed
about his relationship to this case? Was the
paper reviewed by experts in neurotoxicol-
ogy, clinical neurology, and neuropatholo-
gy? Will readers conclude that carbon
disulfide causes multisystem atrophy? How
many more lawsuits will be filed alleging
that since B followed A, A caused B, and
how many more physicians will reach this
vacuous conclusion?
The individual described in this paper
(2) had classical olivopontocerebellar
atrophy, beginning with cerebellar ataxia
and progressing over years to involve long
tracks and cranial nerve nuclei in the pons.
Neither the cerebellum nor the pontine
nuclei are affected in carbon disulfide toxic-
ity. However, Frumkin pointed out that
olivopontocerebellar atrophy is part of a
spectrum of diseases termed multisystem
atrophy, which also includes striatonigral
degeneration, a disease characterized by
clinical parkinsonism. Although extrapyra-
midal involvement in carbon disulfide toxi-
city has been alleged in the clinical literature
(4-11), the only experimental studies
reporting lesions in the extrapyramidal sys-
tem were published over 50 years ago and
involved uncontrolled exposures to carbon
disulfide that resulted in repeated apneic
episodes and confounding hypoxia (12-14).
Extrapyramindal lesions have never been
observed in modern experimental studies,
nor did the patient in Frumkin's report (2)
manifest extrapyramidal signs. On the other
hand, the most sensitive structure in the
nervous system to carbon disulfide-induced
damage is the axon, and this patient never
developed evidence for an axonopathy at
any time during his career or during his ter-
minal illness. Thus Frumkin's statement
that the patient's course ofillness was clini-
cally and pathologically consistent with car-
bon disulfide toxicity has no basis in fact.
Although it certainly was impressive to
see an MRI scan on the cover ofEHP, this
paper is not based in either strong science
or competent clinical medicine. We depend
upon physicians who practice occupational
and environmental medicine to apply the
science of toxicology to the evaluation and
treatment of patients who have been
exposed to toxicants. When the exposure
involves an agent whose toxicity has never
been suspected, case reports have value in
alerting physicians and the public to possi-
ble dangers. Considerable caution must be
exercised, however, in assigning cause-and-
effect relationships between toxicants and
disease, especially when the agent in ques-
tion has been in use for many decades, has
been studied extensively, and has been sub-
jected to strict regulatory standards.
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Carbon Disulfide: Frumkin's
Response
Graham offers four discrete arguments
against an association between carbon
disulfide and olivopontocerebellar atrophy.
First, he holds that olivopontocerebellar
atrophy is clinically incompatible with car-
bon disulfide toxicity because carbon disul-
fide toxicity does not affect the cerebellum
or pontine nuclei. Second, he asserts that
the experimental studies showing extrapyra-
midal involvement in carbon disulfide toxi-
city relied on high-dose exposures at levels
sufficient to cause apnea. Third, he is con-
cerned that this experimental literature is
over 50 years old. Fourth, he argues that
the axon is more sensitive to carbon disul-
fide toxicity than are other parts ofthe ner-
vous system, suggesting that the absence of
axonopathy rules out carbon disulfide toxi-
city. Graham presents these arguments as
ex cathedra pronouncements and cites no
basis for any ofthem. In fact, each is con-
tradicted byavailable evidence.
With regard to cerebellar involvement
in carbon disulfide toxicity, Graham is fac-
tually incorrect. Autopsy studies in humans
with carbon disulfide toxicity are regrettably
rare, but at least two have shown clear evi-
dence of cerebellar involvement (1,2). The
animal toxicology is far more extensive and
has been reviewed in detail (3-5); numerous
reports show cerebellar involvement in
diverse species including rats (6), rabbits
(7), dogs (8), and cats (9). In fact, carbon
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